» Articles » PMID: 29272000

High Expression of LncRNA CASC15 is a Risk Factor for Gastric Cancer Prognosis and Promote the Proliferation of Gastric Cancer

Overview
Date 2017 Dec 23
PMID 29272000
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the expression of long non-coding RNA CASC15 in gastric cancer tissue and its effect on the proliferation of gastric cancer cell line MKN28.

Materials And Methods: We found that expression of lncRNA CASC15 in gastric cancer tissue was higher than normal gastric epithelium through the TCGA and Gene Expression Omnibus (GEO) database. Then, we detect the RNA level of CASC15 from clinical samples of 42 normal gastric epithelial tissues and 60 gastric cancer tissues. In order to explore the function of CASC15 in gastric cancer, we perform gain-function and loss-function assay in gastric cancer cell lines.

Results: We found that expression of lncRNA CASC15 in gastric cancer tissue was higher than normal gastric epithelium through the TCGA database and the related microarray data set was searched from Gene Expression Omnibus (GEO) database.  Then, we extracted total RNA from clinical samples of 42 normal gastric epithelial tissues and 60 gastric cancer tissues. The results of quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) were consistent with those of TCGA analysis. Clinical data analysis showed that the expression of LncRNA CASC15 was correlated with the total survival, tumor size and TMN staging in clinical patients. Clinical data analysis showed that the expression level of CASC15 was correlated with tumor size and TNM stage in clinical patients. Compared with the negative control group, the proliferation and cell cloning ability of MKN28 cells overexpressing LncRNA CASC15 significantly increased (p<0.001), indicating that overexpression of LncRNA CASC15 promoted the proliferation of MKN28 cells.

Conclusions: The expression of LncRNA CASC15 was significantly higher in gastric cancer tissues and its expression was negatively correlated with the overall survival of clinical patients. It was positively correlated with the tumor size and TMN stage. LncRNA CASC15 could promote the proliferation of gastric cancer cells and was expected to become the molecular marker for prediction and prognosis of gastric cancer, as well as a potential therapeutic target.

Citing Articles

Lncrna CASC15 Activated By TCF12 Promote Colorectal Cancer Progression EMT.

Yan S, Yuan M, Yang X, Huang X, Wu D, Wang N Comb Chem High Throughput Screen. 2023; 27(8):1222-1230.

PMID: 37680149 DOI: 10.2174/1386207326666230901120611.


Long non‑coding RNAs, lipid metabolism and cancer (Review).

Zhang Z, Hou X, Cao X, Wang X Exp Ther Med. 2023; 26(4):470.

PMID: 37664674 PMC: 10468807. DOI: 10.3892/etm.2023.12169.


Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma.

Tong F, Xu L, Xu S, Zhang M Front Genet. 2022; 13:834935.

PMID: 36105077 PMC: 9466988. DOI: 10.3389/fgene.2022.834935.


MAGCNSE: predicting lncRNA-disease associations using multi-view attention graph convolutional network and stacking ensemble model.

Liang Y, Zhang Z, Liu N, Wu Y, Gu C, Wang Y BMC Bioinformatics. 2022; 23(1):189.

PMID: 35590258 PMC: 9118755. DOI: 10.1186/s12859-022-04715-w.


LncRNA CASC15, MiR-23b Cluster and SMAD3 form a Novel Positive Feedback Loop to promote Epithelial-Mesenchymal Transition and Metastasis in Ovarian Cancer.

Lin H, Xu X, Chen K, Fu Z, Wang S, Chen Y Int J Biol Sci. 2022; 18(5):1989-2002.

PMID: 35342355 PMC: 8935218. DOI: 10.7150/ijbs.67486.